A significant reduction of the immunoglobulin E levels and the allergen‐specific T cell proliferation was observed in AD patients treated with an anti‐IL‐4Rα ‐antibody, while the allergen‐specific basophil activation/sensitivity were found to be significantly increased. The gene discussed is IL4R; the disease is Alzheimer disease.